Titan Medical Inc. (TMDIF)

USD 0.82

(2173.99%)

EBITDA Summary of Titan Medical Inc.

  • Titan Medical Inc.'s latest annual EBITDA in 2023 was 7.51 Million USD , up 124.9% from previous year.
  • Titan Medical Inc.'s latest quarterly EBITDA in 2024 Q1 was -836.24 Thousand USD , up 75.16% from previous quarter.
  • Titan Medical Inc. reported an annual EBITDA of -39.94 Million USD in 2022, down -40.47% from previous year.
  • Titan Medical Inc. reported an annual EBITDA of -13.85 Million USD in 2021, down -743.16% from previous year.
  • Titan Medical Inc. reported a quarterly EBITDA of -1.1 Million USD for 2024 Q2, down -33.99% from previous quarter.
  • Titan Medical Inc. reported a quarterly EBITDA of N/A for 2023 FY, up 124.9% from previous quarter.

Annual EBITDA Chart of Titan Medical Inc. (2023 - 2016)

Historical Annual EBITDA of Titan Medical Inc. (2023 - 2016)

Year EBITDA EBITDA Growth
2023 7.51 Million USD 124.9%
2022 -39.94 Million USD -40.47%
2021 -13.85 Million USD -743.16%
2020 -24.06 Million USD 107.7%
2019 -42.41 Million USD -61.03%
2018 -21.45 Million USD -92.57%
2017 -34.77 Million USD 28.07%
2016 -23.01 Million USD 0.0%

Peer EBITDA Comparison of Titan Medical Inc.

Name EBITDA EBITDA Difference
Babylon Holdings Limited -176.72 Million USD 104.255%
ETAO International Co., Ltd. -893.88 Million USD 100.841%
MedAvail Holdings, Inc. -41.76 Million USD 118.004%
Micron Solutions, Inc. -308.4 Thousand USD 2538.193%
Motus GI Holdings, Inc. -11.23 Million USD 166.958%
ThermoGenesis Holdings, Inc. -7.74 Million USD 197.15%
UpHealth, Inc. -16.89 Million USD 144.504%